Trials / Completed
CompletedNCT02454803
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
An International, Multicentre, Observational, Prospective, Longitudinal Cohort Study to Assess the Impact of Integrated Upper Limb Spasticity Management Including the Use of BoNT-A- Injections on Patient-centred Goal Attainment in Real Life Practice - ULIS III
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,004 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2019-06-03
- Completion
- 2019-06-03
- First posted
- 2015-05-27
- Last updated
- 2019-08-05
Locations
57 sites across 14 countries: United States, Australia, Austria, Brazil, France, Germany, Hong Kong, Italy, Mexico, Philippines, Poland, Portugal, Russia, Taiwan
Source: ClinicalTrials.gov record NCT02454803. Inclusion in this directory is not an endorsement.